Your browser doesn't support javascript.
loading
The Impact of PSMA-PET on Oncologic Control in Prostate Cancer Patients Who Experienced PSA Persistence or Recurrence.
Bianchi, Lorenzo; Ceci, Francesco; Costa, Francesco; Balestrazzi, Eleonora; Droghetti, Matteo; Piazza, Pietro; Pissavini, Alessandro; Mei, Riccardo; Farolfi, Andrea; Castellucci, Paolo; Puliatti, Stefano; Larcher, Alessandro; Gandaglia, Giorgio; Robesti, Daniele; Mottrie, Alexandre; Briganti, Alberto; Morganti, Alessio Giuseppe; Fanti, Stefano; Montorsi, Francesco; Schiavina, Riccardo; Brunocilla, Eugenio.
Afiliação
  • Bianchi L; Division of Urology, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Ceci F; University of Bologna, 40126 Bologna, Italy.
  • Costa F; Division of Nuclear Medicine, IEO European Institute of Oncology IRCCS, 20141 Milan, Italy.
  • Balestrazzi E; Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.
  • Droghetti M; Division of Urology, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Piazza P; Division of Urology, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Pissavini A; Division of Urology, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Mei R; Division of Urology, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Farolfi A; Division of Urology, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Castellucci P; Nuclear Medicine, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Puliatti S; Nuclear Medicine, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Larcher A; Nuclear Medicine, IRCCS Azienda Ospedaliero-University of Bologna, 40138 Bologna, Italy.
  • Gandaglia G; Department of Urology, University of Modena and Reggio Emilia, 41122 Modena, Italy.
  • Robesti D; Department of Urology, Onze-Lieve-Vrouwziekenhuis, 9300 Aalst, Belgium.
  • Mottrie A; ORSI Academy, 9300 Melle, Belgium.
  • Briganti A; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • Morganti AG; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • Fanti S; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milan, Italy.
  • Montorsi F; Department of Urology, Onze-Lieve-Vrouwziekenhuis, 9300 Aalst, Belgium.
  • Schiavina R; ORSI Academy, 9300 Melle, Belgium.
  • Brunocilla E; Unit of Urology, Division of Experimental Oncology, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Vita-Salute San Raffaele University, 20132 Milan, Italy.
Cancers (Basel) ; 15(1)2022 Dec 30.
Article em En | MEDLINE | ID: mdl-36612242
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Itália